Bluejay Diagnostics, Inc. Records Net Loss of $2.8 Million in Q2 2023

Bluejay Diagnostics, Inc.(BJDX), a leading player in the diagn ostics industry, has released its financial results for the second quarter of 2023, revealing a net loss of $2.8 million and zero revenue for the quarter. The company faced various operating challenges during this period, impacting both its net income and revenue figures.

Net Income/Loss Highlights

In the second quarter of 2023, Bluejay Diagnostics, Inc. reported a net loss of $2.8 million. This represents a significant increase from the net loss of $1.9 million recorded during the same period in the previous year. The company's net loss per share stood at $2.75, compared to $2.00 in the second quarter of 2022.

Revenue Challenges